Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
2000 1
2001 2
2002 5
2003 4
2004 1
2005 4
2006 7
2007 4
2008 9
2009 10
2010 17
2011 14
2012 22
2013 17
2014 11
2015 14
2016 19
2017 19
2018 24
2019 19
2020 11
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

206 results
Results by year
Filters applied: . Clear all
Page 1
Bile Acids and FXR: Novel Targets for Liver Diseases.
Stofan M, Guo GL. Stofan M, et al. Among authors: guo gl. Front Med (Lausanne). 2020 Sep 11;7:544. doi: 10.3389/fmed.2020.00544. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33015098 Free PMC article.
Editorial.
Guo GL, Zhou H. Guo GL, et al. Acta Pharm Sin B. 2015 Mar;5(2):89. doi: 10.1016/j.apsb.2015.03.002. Epub 2015 Mar 25. Acta Pharm Sin B. 2015. PMID: 26579430 Free PMC article. No abstract available.
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R, Yang N, Kong B, Cao B, Feng D, Yu X, Ge C, Huang J, Shen J, Wang P, Feng S, Fei F, Guo J, He J, Aa N, Chen Q, Pan Y, Schumacher JD, Yang CS, Guo GL, Aa J, Wang G. Sun R, et al. Among authors: guo gl. Mol Pharmacol. 2017 Feb;91(2):110-122. doi: 10.1124/mol.116.106617. Epub 2016 Dec 8. Mol Pharmacol. 2017. PMID: 27932556 Free PMC article.
206 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page